Amazon
AMZN
Meritage Homes
MTH
Taylor Morrison Home
TMHC
Toll Brothers
TOL
Alphabet-A
GOOGL
US Stock MarketDetailed Quotes
BPMC Blueprint Medicines
- 109.190
- -0.860-0.78%
Trading Jan 21 11:17 ET
6.94BMarket Cap-52.24P/E (TTM)
110.605High108.155Low117.08KVolume110.240Open110.050Pre Close12.82MTurnover0.19%Turnover RatioLossP/E (Static)63.53MShares121.90052wk High22.15P/B6.86BFloat Cap72.24052wk Low--Dividend TTM62.86MShs Float125.610Historical High--Div YieldTTM2.23%Amplitude13.040Historical Low109.466Avg Price1Lot Size
About Blueprint Medicines Company
Blueprint Medicines Corp. is a precision therapy company, which engages in the invention of medicines for people with cancer and blood disorders. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.
Company Profile
SymbolBPMC
Company NameBlueprint Medicines
Listing DateApr 30, 2015
Issue Price18.00
Founded2008
CEOMs. Kathryn Haviland
MarketNASDAQ
Employees655
Fiscal Year Ends12-31
Address45 Sidney Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-617-374-7580
Company Executives
- Name
- Position
- Salary
- Kathryn Haviland
- Director, President and Chief Executive Officer
- 6.43M
- Dr. Christopher K. Murray, PhD
- Chief Technical Operations and Quality Officer
- --
- Dr. Philina Lee, PhD
- Chief Commercial Officer
- --
- Dr. Percy H. Carter, M.B.A.,PhD
- Chief Scientific Officer
- 2.30M
- Debra Durso-Bumpus
- Chief People Officer
- --
- Christina Rossi, M.B.A.
- Chief Operating Officer
- 2.81M
- Dr. Becker Hewes, M.D.
- Chief Medical Officer
- --
- Tracey L. McCain, Esq.
- Chief Legal and Compliance Officer
- --
- Michael Landsittel, M.B.A.
- Chief Financial Officer
- 2.19M
- Ariel Hurley
- Senior Vice President, Finance and Principal Accounting Officer
- --
- Jeffrey W. Albers, J.D.
- Chairman of the Board
- 526.08K
- Dr. Fouad Namouni, M.D.
- President, Research and Development
- 2.80M
- Alexis A. Borisy, A.M.
- Director
- 397.33K
- Dr. Nicholas Lydon, F.R.S.,PhD
- Independent Director
- 417.33K
- Lonnel Coats
- Independent Director
- 419.33K
- Dr. Mark Alan Goldberg, M.D.
- Independent Director
- 419.33K
- Daniella Beckman
- Independent Director
- 422.33K
- Dr. John Tsai, M.D.
- Independent Director
- 769.80K
- Dr. Lynn Seely,M.D.
- Lead Independent Director
- 452.33K
- Habib Joseph Dable
- Independent Director
- 412.33K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
